Abstract
Classical pharmaceutical research and development relies on the identification and validation of i) membranepermeable small molecules or ii) extracellular targets that are able to interfere with cellular key signaling pathways. During the last two decades the direct intracellular delivery of macromolecules developed into a novel paradigm to manipulate cell functions. This technique, commonly referred to as protein transduction, is based on the ability of certain peptides, designated as cell penetrating peptides (CPPs), to cross the cell membrane and deliver cargos such as peptides and proteins. Although protein transduction has been widely applied the process of cellular uptake remains poorly understood and therapeutic applications are rare thus far. The mechanism by which CPP-modified proteins adhere to, and cross the plasma membrane of cells as well as the subsequent intracellular trafficking is currently extensively investigated. While there is consent that CPP-cargos are internalized via endocytotic pathways the actual membrane translocation mechanism remains unclear. Recent studies indicate that CPP-cargo trapped in endosomal vesicles can be released into the cytosol by direct membrane perturbation or by retrograde delivery as demonstrated for various toxins. The present review seeks to outline the current state-of-the-art concerning the mechanism of protein transduction. A further mechanistic understanding will be critical to design transduction strategies that may open the door for cell-impermeable compounds to become intracellular effectors.
Keywords: Protein transduction, endocytosis, retrograde delivery, protein therapy
Current Pharmaceutical Design
Title: Protein Transduction Revisited: Novel Insights Into the Mechanism Underlying Intracellular Delivery of Proteins
Volume: 14 Issue: 34
Author(s): Frank Edenhofer
Affiliation:
Keywords: Protein transduction, endocytosis, retrograde delivery, protein therapy
Abstract: Classical pharmaceutical research and development relies on the identification and validation of i) membranepermeable small molecules or ii) extracellular targets that are able to interfere with cellular key signaling pathways. During the last two decades the direct intracellular delivery of macromolecules developed into a novel paradigm to manipulate cell functions. This technique, commonly referred to as protein transduction, is based on the ability of certain peptides, designated as cell penetrating peptides (CPPs), to cross the cell membrane and deliver cargos such as peptides and proteins. Although protein transduction has been widely applied the process of cellular uptake remains poorly understood and therapeutic applications are rare thus far. The mechanism by which CPP-modified proteins adhere to, and cross the plasma membrane of cells as well as the subsequent intracellular trafficking is currently extensively investigated. While there is consent that CPP-cargos are internalized via endocytotic pathways the actual membrane translocation mechanism remains unclear. Recent studies indicate that CPP-cargo trapped in endosomal vesicles can be released into the cytosol by direct membrane perturbation or by retrograde delivery as demonstrated for various toxins. The present review seeks to outline the current state-of-the-art concerning the mechanism of protein transduction. A further mechanistic understanding will be critical to design transduction strategies that may open the door for cell-impermeable compounds to become intracellular effectors.
Export Options
About this article
Cite this article as:
Edenhofer Frank, Protein Transduction Revisited: Novel Insights Into the Mechanism Underlying Intracellular Delivery of Proteins, Current Pharmaceutical Design 2008; 14 (34) . https://dx.doi.org/10.2174/138161208786898833
DOI https://dx.doi.org/10.2174/138161208786898833 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
Current Drug Targets Emerging Therapeutic Approaches Based on Nanotechnology for the Treatment of Diseases Associated with Telomere Dysfunction
Mini-Reviews in Medicinal Chemistry Neurokinin-1 Receptor Antagonists as Anticancer Drugs
Letters in Drug Design & Discovery Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design Recent Advances in Mesoporous Silica and Gold Based Nanovectors in Anticancer Drug Delivery System
Current Organic Chemistry Second Generation Taxanes: from the Natural Framework to the Challenge of Drug Resistance
Current Medicinal Chemistry - Anti-Cancer Agents In Vivo Tumor Secretion Probing Via Ultrafiltration and Tissue Chamber:Implication for Anti-Cancer Drugs Targeting Secretome
Recent Patents on Anti-Cancer Drug Discovery Delivery of Nanoparticles for Treatment of Brain Tumor
Current Drug Metabolism Crude Venom from Nematocysts of the Jellyfish Pelagia noctiluca as a Tool to Study Cell Physiology
Central Nervous System Agents in Medicinal Chemistry Novel Homeodomain Transcription Factor Nkx2.2 in the Brain Tumor Development
Current Cancer Drug Targets Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer
Current Molecular Medicine The Role of Circulating Endothelial Progenitor Cells in Tumor Angiogenesis
Current Stem Cell Research & Therapy Aneurysm of the Communicating Vein Between the Left Renal Vein and Left Ascending Lumbar Vein Mimicking Retroperitoneal Lymphadenopathy: A Case Report
Current Medical Imaging Microglial Activation and its Implications in the Brain Diseases
Current Medicinal Chemistry Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature
Current Drug Targets Salen Mn Complexes Mitigate Radiation Injury in Normal Tissues
Anti-Cancer Agents in Medicinal Chemistry Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Anti-Cancer Agents in Medicinal Chemistry Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway
Current Cancer Drug Targets Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors
Recent Patents on Anti-Cancer Drug Discovery